Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02516917
Other study ID # 163562
Secondary ID
Status Completed
Phase N/A
First received July 31, 2015
Last updated October 24, 2016
Start date August 2015
Est. completion date May 2016

Study information

Verified date October 2016
Source University of Manchester
Contact n/a
Is FDA regulated No
Health authority United Kingdom: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

This study aims to investigate the application of the Attention Training Technique in children with ADHD aged 7-11 years old. The research aims to investigate both the feasibility of this technique in this population as well as whether it can improve symptoms, behaviour and executive functioning.


Description:

Attention deficit hyperactivity disorder (ADHD) is a neurobehavioural disorder characterised by core symptoms of hyperactivity, impulsivity and inattention. Its prevalence ranges between 3-9% of school-aged children, making it one of the most common presentations in child and adolescent mental health services.

In the last 10 years, research into the effectiveness of attention training as an intervention for children with ADHD has been increasing. This has tended to follow assumptions that children with the disorder either lack skills in focusing and maintaining their attention and/or have neurological deficits in areas responsible for attention functions. Results have been encouraging, with study participants demonstrating improvements in symptoms and behaviour following a course of attention training. However, the method and length of training has varied across studies.

This study aims to investigate a treatment called the Attention Training Technique (ATT) that approaches attention difficulties in this disorder from a different perspective. Instead of viewing inattention as a result of structural or skills deficits, it posits that children with ADHD have these skills, but are perhaps unaware of the flexibility and control they have over them. This treatment aims to increase this awareness and subsequently improve ratings of attention, behaviour and other areas of executive functioning.


Recruitment information / eligibility

Status Completed
Enrollment 13
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 7 Years to 11 Years
Eligibility Inclusion Criteria:

- Children with a formal diagnosis of ADHD as given by a psychiatrist or community paediatrician

- Children between the ages of 7 and 11. This age group was selected as previous research on attention training in this population has used this age group

- Children who are currently on a waiting list at a Child and Adolescent Mental Health Service (CAMHS) or a child psychology service, or being seen by a CAMHS or psychology service for medication review only

- Children who speak fluent English which will ensure they are able to comprehend the tasks instructions adequately.

Exclusion Criteria:

- Children who are not stabilised on stimulant medication and/or willing to maintain their medication type/dose

- Children with a major neurological illness or acquired central nervous system injury

- Children who at the point of referral have a co-existing diagnosis of an Autistic Spectrum Disorder

- Children who are currently in receipt of another non-pharmacological intervention for ADHD or who are currently taking part in another research trial

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Attention Deficit Disorder with Hyperactivity
  • Attention Deficit Hyperactivity Disorder

Intervention

Behavioral:
Attention Training Technique


Locations

Country Name City State
United Kingdom University of Manchester Manchester

Sponsors (1)

Lead Sponsor Collaborator
University of Manchester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Inattention on the Swanson, Nolan and Pelham questionnaire (Snap-IV) Parent's rating of their child's inattentiveness Change from baseline in attention post treatment and at follow up 6 weeks later No
Secondary Hyperactivity on the Swanson, Nolan and Pelham questionnaire (Snap-IV) Parent's rating of their child's hyperactivity Change from baseline in hyperactivity post treatment and at follow up 6 weeks later No
Secondary Impulsivity on the Swanson, Nolan and Pelham questionnaire (Snap-IV) Parent's rating of their child's impulsivity Change from baseline in impulsivity post treatment and at follow up 6 weeks later No
Secondary Attentional control on the Attentional Control Scale for Children (ASC-C) Children's self reported ability to focus and shift their attention Change from baseline in attentional control post treatment and at follow up 6 weeks later No
Secondary Behaviour on the Strengths and Difficulties Questionnaire (SDQ) Parent's ratings of their child's behaviours Change from baseline in behaviour post treatment and at follow up 6 weeks later No
Secondary Executive functioning on The Behavioural Rating Inventory of Executive Functioning (BRIEF) Parent's ratings of their child's executive functioning behaviours in the home environment Change from baseline in executive functioning post treatment and at follow up 6 weeks later No
Secondary Working memory on the Weschler Intelligence Scale for Children (WISC-IV) - Digit Span Children's Working memory as assessed by the Digit Span subtest Change from baseline in working memory post treatment and at follow up 6 weeks later No
Secondary Working memory on the Weschler Intelligence Scale for Children (WISC-IV) - Letter Number Sequencing Children's Working memory as assessed by the Letter Number Sequencing subtest Change from baseline in working memory post treatment and at follow up 6 weeks later No
Secondary Treatment Acceptability Questionnaire Parents rating of the acceptability of the treatment Rated once at the final session of treatment, 4 weeks after the 2nd baseline is taken No
See also
  Status Clinical Trial Phase
Recruiting NCT06129396 - Effects of Aerobic Exercise Intervention in Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD) N/A
Completed NCT04779333 - Lifestyle Enhancement for ADHD Program 2 N/A
Recruiting NCT05935722 - Evaluation of a Home-based Parenting Support Program: Parenting Young Children N/A
Completed NCT03148782 - Brain Plasticity Underlying Acquisition of New Organizational Skills in Children-R61 Phase N/A
Completed NCT04832737 - Strength-based Treatment Approach for Adults With ADHD N/A
Recruiting NCT04631042 - Developing Brain, Impulsivity and Compulsivity
Recruiting NCT05048043 - Development of a Game-supported Intervention N/A
Completed NCT03337646 - Evaluation of the Effect and Safety of Lisdexamfetamine in Children Aged 6-12 With ADHD and Autism Phase 4
Not yet recruiting NCT06080373 - Formulation-based CBT for Adult Inmates With ADHD: A Randomized Controlled Trial N/A
Not yet recruiting NCT06406309 - Settling Down for Sleep in ADHD: The Impact of Sensory and Arousal Systems on Sleep in ADHD N/A
Not yet recruiting NCT06454604 - Virtual Reality Treatment for Emerging Adults With ADHD Phase 2
Completed NCT02477280 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance Phase 4
Completed NCT02911194 - a2 Milk for Autism and Attention-deficit Hyperactivity Disorder (ADHD) N/A
Completed NCT02390791 - New Technologies to Help Manage ADHD N/A
Completed NCT02473185 - Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the QbTest Phase 4
Completed NCT02829970 - Helping College Students With ADHD Lead Healthier Lifestyles N/A
Completed NCT02780102 - Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD N/A
Completed NCT02555150 - A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD Phase 3
Recruiting NCT04296604 - Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations N/A
Recruiting NCT04175028 - Neuromodulation of Executive Function in the ADHD Brain N/A